Abstract 298P
Background
It was still controversial regarding the postoperative preservation of pulmonary function after segmentectomy over lobectomy. In particular, resection for three or more segment was associated with more profound decreased in lung function. The purpose of this study was to investigate the effect of left upper division (LUD) segmentectomy on postoperative pulmonary function and lung volume comparison of left upper lobectomy among clinical stage IA non-small cell lung cancer (NSCLC).
Methods
Among clinical stage IA NSCLC patients who underwent LUD segmentectomy or left upper lobectomy between 2013 and 2018, postoperative changes in pulmonary function, 3-dimensional computed tomography (CT) volumetry and the percentage of low attenuation areas (% LAAs) were retrospectively reviewed according to surgical procedure. Changes in pulmonary function by groups were compared using linear mixed model with linear spline, random intercepts and slope.
Results
A total of 264 patient were identified, the study group consisted with 85 LUD segmentectomy (32.2%) and 179 left lobectomy (67.8%). In the adjusted model, no significant difference was observed among changes in pulmonary function by surgical procedure. In terms of lung volume, postoperative volume in contralateral lung and LLL was increased in both groups, it is more likely to have greater increase in LLL volume in lobectomy group (333.4 vs. 451.6 ml, p<0.001) than those in segmentectomy group. After surgery, the % LAA of left lung and LLL in the lobectomy group significantly increased compared to those in the segmentectomy group (0.37 vs. 1.31, p=0.002; 0.53 vs. 1.82, p<0.001), while change of % LAA of right lung was not significantly differ by surgical procedure. In the linear regression model, changes in lung volume and % LAA in left lung and LLL was significantly associated with type of surgery.
Conclusions
Postoperative changes in pulmonary function after LUD segmentectomy and left upper lobectomy was not significantly different. However, segmentectomy was significantly associated with less volume expansion and less increased % LAA compared with those in lobectomy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
314P - Let’s bring back old drugs to conquer resistance to KRAS G12C inhibitors in NSCLC
Presenter: Anisha Jain
Session: Poster viewing 04
315P - Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A single-center experience
Presenter: Luka Brcic
Session: Poster viewing 04
316P - Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate
Presenter: Ryosuke Ogata
Session: Poster viewing 04
317P - A project to investigate the actual status of biomarker testing in unresectable advanced or recurrent non-small cell lung cancer: WJOG15421 L (REVEAL)
Presenter: Taichi Matsubara
Session: Poster viewing 04